» Articles » PMID: 34659121

Xanthomatous Hypophysitis: A Case Report and Comprehensive Literature Review

Overview
Specialty Endocrinology
Date 2021 Oct 18
PMID 34659121
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Xanthomatous hypophysitis (XHP) is an extremely rare form of primary hypophysitis for which there is a lack of clinical experience. A comprehensive understanding of its clinical characteristics, diagnosis and treatment is needed.

Methods: Here, we report a case study and conduct a systematic review of XHP. Thirty-six cases were included, and their clinical manifestations, endocrine assessment, imaging features, treatment and follow-up data were collected and analyzed.

Results: The mean age at diagnosis was 39.1 years, and females were predominant (75.0%). The most common symptom was headache (68.6%), and 66.7% of female patients presented menstrual disorders. The most common pituitary dysfunction was growth hormone (GH) deficiency. More than half of patients exhibited central diabetes insipidus (CDI). The majority of patients had an imaging presentation of a cystic lesion with peripheral enhancement. Pituitary stalk thickening was observed in half of the patients. Total lesion resection was achieved in 57.1% of cases. The recurrence rate after partial resection and biopsy was significantly higher than that after total lesion resection (57.1% 0.0%, P = 0.0147). The most common pituitary hormone abnormalities to resolve after surgery were hyperprolactinemia (100.0%) and GH deficiency (91.7%). The typical pathological feature was inflammatory infiltration of foamy histiocytes, which showed positivity for CD68.

Conclusion: Diagnosis of XHP is difficult when relying on clinical symptoms and imaging features. Therefore, surgical histopathology is necessary. Based on the available evidence, total lesion resection is recommended for treatment. However, the long-term prognosis for this rare disease remains unclear.

Citing Articles

Secondary xanthogranulomatous hypophysitis mimicking a pituitary macroadenoma: a case report.

Salhi S, Oueslati I, Mouelhi Y, Zehani A, Kchir N, Kamoun E J Int Med Res. 2024; 52(1):3000605231223033.

PMID: 38190975 PMC: 10775730. DOI: 10.1177/03000605231223033.


Xanthogranulomatous hypophysitis: A rare presentation in a young female patient.

Yaghoubi M, Zabihyan S, Saeidinia A, Gharib M, Ghiyasi Moghaddam R Clin Case Rep. 2022; 10(9):e6337.

PMID: 36177067 PMC: 9474903. DOI: 10.1002/ccr3.6337.


Successful immunomodulatory treatment for recurrent xanthogranulomatous hypophysitis in an adolescent: illustrative case.

DeCou S, Recinos P, Prayson R, Karakasis C, Haider A, Patel N J Neurosurg Case Lessons. 2022; 4(9):CASE22191.

PMID: 36051774 PMC: 9426350. DOI: 10.3171/CASE22191.

References
1.
Gutenberg A, Hans V, Puchner M, Kreutzer J, Bruck W, Caturegli P . Primary hypophysitis: clinical-pathological correlations. Eur J Endocrinol. 2006; 155(1):101-7. DOI: 10.1530/eje.1.02183. View

2.
Cheung C, Ezzat S, Smyth H, Asa S . The spectrum and significance of primary hypophysitis. J Clin Endocrinol Metab. 2001; 86(3):1048-53. DOI: 10.1210/jcem.86.3.7265. View

3.
Young Joung J, Jeong H, Cho Y, Huh K, Suh Y, Kim K . Steroid responsive xanthomatous hypophysitis associated with autoimmune thyroiditis: a case report. Endocrinol Metab (Seoul). 2014; 28(1):65-9. PMC: 3811790. DOI: 10.3803/EnM.2013.28.1.65. View

4.
Tang F, Liu H, Zhou S, Liu J, Xiao E, Tan C . MRI manifestation of xanthomatous hypophysitis: a case report and review of the literature. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2015; 40(2):228-32. DOI: 10.11817/j.issn.1672-7347.2015.02.019. View

5.
Deodhare S, Bilbao J, Kovacs K, Horvath E, Nomikos P, Buchfelder M . Xanthomatous Hypophysitis: A Novel Entity of Obscure Etiology. Endocr Pathol. 2002; 10(3):237-241. DOI: 10.1007/BF02738885. View